O
AGN

OrbiMed’s Allergan Inc AGN Stock Holding History

OrbiMed’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-250,000
Closed -$53.1M – 155
2014
Q4 		$53.1M Buy
+250,000
New +$49.7M 0.51% 46
2014
Q3 		– Sell
-250,000
Closed -$42.3M – 159
2014
Q2 		$42.3M Buy
250,000
+50,000
+25% +$7.78M 0.5% 48
2014
Q1 		$24.8M Buy
+200,000
New +$24.4M 0.31% 57

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

OrbiMed's AGN Position: Q1 2015 in Review

OrbiMed sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 741,300 shares — an estimated $158M sold.

OrbiMed first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $282M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • OrbiMed reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • OrbiMed sold 741,300 Allergan Inc shares in Q1 2015, an estimated $158M.
  • OrbiMed first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • OrbiMed's Allergan Inc position peaked at $282M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on OrbiMed's 13F filing for Q1 2015, filed 15 May 2015.